Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2014, Article ID 183167, 15 pages
http://dx.doi.org/10.1155/2014/183167
Review Article

Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health

1Teaching Institute of Public Health “Dr Andrija Štampar” and School of Medicine, University of Zagreb, Šalata 3b, 10000 Zagreb, Croatia
2Clinical Microbiology and Parasitology Unit, Polyclinic “Dr Zora Profozić”, Bosutska 19, 10000 Zagreb, Croatia

Received 29 September 2014; Revised 9 December 2014; Accepted 11 December 2014; Published 31 December 2014

Academic Editor: Nongnuch Vanittanakom

Copyright © 2014 Sunčanica Ljubin-Sternak and Tomislav Meštrović. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Department of Reproductive Health and Research World Health Organization, Global Strategy for the Prevention and Control of Sexually Transmitted Infections: 2006–2015, WHO Press, Geneva, Switzerland, 2007.
  2. A. Gewirtzman, L. Bobrick, K. Conner, and S. K. Tyring, “Epidemiology of sexually transmitted infections,” in Sexually Transmitted Infections and Sexually Transmitted Diseases, G. Gorss and S. K. Tyring, Eds., Springer, New York, NY, USA, 2011. View at Google Scholar
  3. O. Yeganeh, M. Jeddi-Tehrani, F. Yaghmaie et al., “A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of Labbafinejad Hospital, Tehran, Iran,” Iranian Red Crescent Medical Journal, vol. 15, no. 4, pp. 340–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. A. Cunningham and K. W. Beagley, “Male genital tract chlamydial infection: implications for pathology and infertility,” Biology of Reproduction, vol. 79, no. 2, pp. 180–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Simms, K. Eastick, H. Mallinson et al., “Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease,” Sexually Transmitted Infections, vol. 79, no. 2, pp. 154–156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Miron, D. Socolov, M. Mareş et al., “Bacteriological agents which play a role in the development of infertility,” Acta Microbiologica et Immunologica Hungarica, vol. 60, no. 1, pp. 41–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. S. Stephens, S. Kalman, C. Lammel et al., “Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis,” Science, vol. 282, no. 5389, pp. 754–759, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Carlson, W. M. Whitmire, D. D. Crane et al., “The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor,” Infection and Immunity, vol. 76, no. 6, pp. 2273–2283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Comanducci, R. Cevenini, A. Moroni et al., “Expression of a plasmid gene of Chlamydia trachomatis encoding a novel 28 kDa antigen,” Journal of General Microbiology, vol. 139, no. 5, pp. 1083–1092, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ripa and P. A. Nilsson, “A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests,” Sexually Transmitted Diseases, vol. 34, no. 5, pp. 255–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. W. Moulder, “Interaction of chlamydiae and host cells in vitro,” Microbiological Reviews, vol. 55, no. 1, pp. 143–190, 1991. View at Google Scholar · View at Scopus
  12. P. M. Bavoil, R.-C. Hsia, and D. M. Ojcius, “Closing in on Chlamydia and its intracellular bag of tricks,” Microbiology, vol. 146, part 11, pp. 2723–2731, 2000. View at Google Scholar · View at Scopus
  13. P. B. Wyrick, “Chlamydia trachomatis persistence in vitro: an overview,” The Journal of Infectious Diseases, vol. 201, supplement 2, pp. S88–S95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Kintner, D. Lajoie, J. Hall, J. Whittimore, and R. V. Schoborg, “Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations,” Frontiers in Cellular and Infection Microbiology, vol. 4, article 44, 2014. View at Publisher · View at Google Scholar
  15. M. Malhotra, S. Sood, A. Mukherjee, S. Muralidhar, and M. Bala, “Genital Chlamydia trachomatis: an update,” Indian Journal of Medical Research, vol. 138, pp. 303–316, 2013. View at Google Scholar · View at Scopus
  16. H. Abdelsamed, J. Peters, and G. I. Byrne, “Genetic variation in Chlamydia trachomatis and their hosts: Impact on disease severity and tissue tropism,” Future Microbiology, vol. 8, no. 9, pp. 1129–1146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. I. Byrne, “Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity,” Journal of Infectious Diseases, vol. 201, no. 2, pp. S126–S133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Kinnunen, H.-M. Surcel, M. Lehtinen et al., “HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study,” Human Reproduction, vol. 17, no. 8, pp. 2073–2078, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. K. B. Waites and D. Taylor-Robinson, “Mycoplasma and ureaplasma,” in Manual of Clinical Microbiology, J. Versalovic, K. Carroll, G. Funke, J. Jorgensen, M. Landry, and D. W. Warnock, Eds., ASM Press, Washington, DC, USA, 10th edition, 2011. View at Google Scholar
  20. C. Citti and A. Blanchard, “Mycoplasmas and their host: emerging and re-emerging minimal pathogens,” Trends in Microbiology, vol. 21, no. 4, pp. 196–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Uusküla and P. K. Kohl, “Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents,” International Journal of STD and AIDS, vol. 13, no. 2, pp. 79–85, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Fraser, J. D. Gocayne, O. White et al., “The minimal gene complement of Mycoplasma genitalium,” Science, vol. 270, no. 5235, pp. 397–403, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. K. B. Waites, B. Katz, and R. L. Schelonka, “Mycoplasmas and ureaplasmas as neonatal pathogens,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 757–789, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Henrich, R.-C. Feldmann, and U. Hadding, “Cytoadhesins of Mycoplasma hominis,” Infection and Immunity, vol. 61, no. 7, pp. 2945–2951, 1993. View at Google Scholar · View at Scopus
  25. P. C. Hu, U. Schaper, A. M. Collier et al., “A Mycoplasma genitalium protein resembling the Mycoplasma pneumoniae attachment protein,” Infection and Immunity, vol. 55, no. 5, pp. 1126–1131, 1987. View at Google Scholar · View at Scopus
  26. C. Citti, L.-X. Nouvel, and E. Baranowski, “Phase and antigenic variation in mycoplasmas,” Future Microbiology, vol. 5, no. 7, pp. 1073–1085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. N. Peterson, C. C. Bailey, J. S. Jensen et al., “Characterization of repetitive DNA in the Mycoplasma genitalium genome: possible role in the generation of antigenic variation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 25, pp. 11829–11833, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Li, M. Krishnan, J. B. Baseman, and T. R. Kannan, “Molecular cloning, expression, and characterization of a Ca2+-dependent, membrane-associated nuclease of Mycoplasma genitalium,” Journal of Bacteriology, vol. 192, no. 19, pp. 4876–4884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. L. Swanberg, G. K. Masover, and L. Hayflick, “Some characteristics of Ureaplasma urealyticum. Urease activity in a simple buffer: effect of metal ions and sulphydryl inhibitors,” Journal of General Microbiology, vol. 108, no. 2, pp. 221–225, 1978. View at Publisher · View at Google Scholar · View at Scopus
  30. R. K. Spooner, W. C. Russell, and D. Thirkell, “Characterization of the immunoglobulin A protease of Ureaplasma urealyticum,” Infection and Immunity, vol. 60, no. 6, pp. 2544–2546, 1992. View at Google Scholar · View at Scopus
  31. S. Rottem, “Interaction of mycoplasmas with host cells,” Physiological Reviews, vol. 83, no. 2, pp. 417–432, 2003. View at Google Scholar · View at Scopus
  32. J. B. Baseman and J. G. Tully, “Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety,” Emerging Infectious Diseases, vol. 3, no. 1, pp. 21–32, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. S. F. Dallo and J. B. Baseman, “Intracellular DNA replication and long-term survival of pathogenic mycoplasmas,” Microbial Pathogenesis, vol. 29, no. 5, pp. 301–309, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Kucinskiene, I. Sutaite, S. Valiukeviciene, Z. Milasauskiene, and M. Domeika, “Prevalence and risk factors of genital Chlamydia trachomatis infection,” Medicina, vol. 42, no. 11, pp. 885–894, 2006. View at Google Scholar · View at Scopus
  35. Division of STD Prevention Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, “Sexually Transmitted Disease Surveillance 2012,” http://www.cdc.gov/std/stats12/surv2012.pdf.
  36. E. Eggleston, S. M. Rogers, C. F. Turner et al., “Chlamydia trachomatis infection among 15-to 35-year-olds in Baltimore, MD,” Sexually Transmitted Diseases, vol. 38, no. 8, pp. 743–749, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Goulet, B. De Barbeyrac, S. Raherison, M. Prudhomme, C. Semaille, and J. Warszawski, “Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France,” Sexually Transmitted Infections, vol. 86, no. 4, pp. 263–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Božičević, I. Grgić, S. Židovec-Lepej et al., “Urine-based testing for Chlamydia trachomatis among young adults in a population-based survey in Croatia: feasibility and prevalence,” BMC Public Health, vol. 11, article 230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. L. Sternak, V. Kružić, T. Vilibić-Čavlek, and V. Skerk, “Chlamydia trachomatis infection in Croatian symptomatic and asymptomatic men [1],” Journal of Men's Health and Gender, vol. 3, no. 1, pp. 80–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Škerk, V. Čajić, L. Markovinović et al., “Etiology of chronic prostatitis syndrome in patients treated at the university hospital for infectious diseases “Dr. Fran Mihaljević” from 2003 to 2005,” Collegium Antropologicum, vol. 30, supplement 2, pp. 145–149, 2006. View at Google Scholar · View at Scopus
  41. M. Pasini, V. Kotarski, V. Škerk et al., “The significance of Chlamydia trachomatis in prostatitis syndrome,” Journal of Chemotherapy, vol. 26, no. 6, pp. 382–384, 2014. View at Google Scholar
  42. G. M. Daley, D. B. Russell, S. N. Tabrizi, and J. McBride, “Mycoplasma genitalium: a review,” International Journal of STD & AIDS, vol. 25, no. 7, pp. 475–487, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Falk, H. Fredlund, and J. S. Jensen, “Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis,” Sexually Transmitted Infections, vol. 80, no. 4, pp. 289–293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Sethi, G. Singh, P. Samanta, and M. Sharma, “Mycoplasma genitalium: an emerging sexually transmitted pathogen,” Indian Journal of Medical Research, vol. 136, no. 6, pp. 942–955, 2012. View at Google Scholar · View at Scopus
  45. N. Ružman, M. Miškulin, S. Rudan, and Z. Bošnjak, “The prevalence and the risk factors of the cervical colonization by the genital mycoplasmas among pregnant women from Eastern Croatia,” Collegium Antropologicum, vol. 37, no. 1, pp. 135–140, 2013. View at Google Scholar · View at Scopus
  46. B. Hunjak, I. Sabol, G. Vojnović et al., “Ureaplasma urealyticum and Ureaplasma parvum in women of reproductive age,” Archives of Gynecology and Obstetrics, vol. 289, no. 2, pp. 407–412, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Plečko, L. Žele Starčević, V. Tripković, V. Rezo Vranješ, and M. Skerlev, “Mycoplasma genitalium: clinical significance and diagnosis,” Acta Dermatovenerologica Croatica, vol. 21, no. 4, pp. 236–240, 2013. View at Google Scholar · View at Scopus
  48. M. Berntson and P. Tunbäck, “Clinical and microscopic signs of cervicitis and urethritis: correlation with Chlamydia trachomatis infection in female STI patients,” Acta Dermato-Venereologica, vol. 93, no. 2, pp. 230–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Paavonen and W. Eggert-Kruse, “Chlamydia trachomatis: impact on human reproduction,” Human Reproduction Update, vol. 5, no. 5, pp. 433–447, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. M. J. W. van de Laar and S. A. Morré, “Chlamydia: a major challenge for public health,” Euro Surveillance, vol. 12, no. 10, pp. E1–E2, 2007. View at Google Scholar · View at Scopus
  51. C. L. Haggerty, S. L. Gottlieb, B. D. Taylor, N. Low, F. Xu, and R. B. Ness, “Risk of sequelae after Chlamydia trachomatis genital infection in women,” The Journal of Infectious Diseases, vol. 201, supplement 2, pp. S134–S155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. S. A. Herzog, C. L. Althaus, J. C. M. Heijne et al., “Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study,” BMC Infectious Diseases, vol. 12, article 187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. J. Price, A. E. Ades, D. de Angelis et al., “Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model,” American Journal of Epidemiology, vol. 178, no. 3, pp. 484–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Schindlbeck, D. Dziura, and I. Mylonas, “Diagnosis of pelvic inflammatory disease (PID): intra-operative findings and comparison of vaginal and intra-abdominal cultures,” Archives of Gynecology and Obstetrics, vol. 289, no. 6, pp. 1263–1269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. L. V. Westrom, “Sexually transmitted diseases and infertility,” Sexually Transmitted Diseases, vol. 21, supplement 2, pp. S32–S37, 1994. View at Google Scholar · View at Scopus
  56. K. Agholor, L. Omo-Aghoja, and F. Okonofua, “Association of anti-Chlamydia antibodies with ectopic pregnancy in Benin city, Nigeria: a case-control study,” African Health Sciences, vol. 13, no. 2, pp. 430–440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Naderi, F. Kazerani, and A. Bahrampoor, “Comparison of Chlamydia infection prevalence between patients with and without ectopic pregnancy using the PCR method,” Ginekologia Polska, vol. 83, no. 11, pp. 819–821, 2012. View at Google Scholar · View at Scopus
  58. H. C. Wiesenfeld, S. L. Hillier, L. A. Meyn, A. J. Amortegui, and R. L. Sweet, “Subclinical pelvic inflammatory disease and infertility,” Obstetrics and Gynecology, vol. 120, no. 1, pp. 37–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Debattista, C. M. Gazzard, R. N. Wood et al., “Interaction of microbiology and pathology in women undergoing investigations for infertility,” Infectious Disease in Obstetrics and Gynecology, vol. 12, no. 3-4, pp. 135–145, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Mania-Pramanik, S. Kerkar, S. Sonawane, P. Mehta, and V. Salvi, “Current Chlamydia trachomatis infection, a major cause of infertility,” Journal of Reproduction and Infertility, vol. 13, no. 4, pp. 204–210, 2012. View at Google Scholar · View at Scopus
  61. G. I. J. G. Rours, R. R. de Krijger, A. Ott et al., “Chlamydia trachomatis and placental inflammation in early preterm delivery,” European Journal of Epidemiology, vol. 26, no. 5, pp. 421–428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Djukić, M. Nedeljković, M. Pervulov, A. Ljubić, N. Radunović, and B. Lazarević, “Intra-amniotic Chlamydia trachomatis infection,” Gynecologic and Obstetric Investigation, vol. 42, no. 2, pp. 109–112, 1996. View at Publisher · View at Google Scholar · View at Scopus
  63. M. J. P. M. de Attayde Silva, G. L. Dantas Florêncio, J. R. Erbolato Gabiatti, R. L. do Amaral, J. E. Júnior, and A. K. da Silveira Gonçalves, “Perinatal morbidity and mortality associated with chlamydial infection: a meta-analysis study,” Brazilian Journal of Infectious Diseases, vol. 15, no. 6, pp. 533–539, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. G. G. G. Donders, P. Moerman, G. H. de Wet, P. Hooft, and P. Goubau, “The association between Chlamydia cervicitis, chorioamnionitis and neonatal complications,” Archives of Gynecology and Obstetrics, vol. 249, no. 2, pp. 79–85, 1991. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Gencay, M. Koskiniemi, P. Saikku et al., “Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications,” Clinical Infectious Diseases, vol. 21, no. 2, pp. 424–426, 1995. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Hernandez-Trejo, N. E. Herrera-Gonzalez, M. R. Escobedo-Guerra et al., “Reporting detection of Chlamydia trachomatis DNA in tissues of neonatal death cases,” Jornal de Pediatria, vol. 90, no. 2, pp. 182–189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. M. M. Blas, F. A. Canchihuaman, I. E. Alva, and S. E. Hawes, “Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State,” Sexually Transmitted Infections, vol. 83, no. 4, pp. 314–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Shariat, M. Young, and M. Abedin, “An interesting case presentation: a possible new route for perinatal acquisition of Chlamydia,” Journal of Perinatology, vol. 12, no. 3, pp. 300–302, 1992. View at Google Scholar · View at Scopus
  69. G. I. J. G. Rours, R. R. de Krijger, A. Ott et al., “Chlamydia trachomatis and placental inflammation in early preterm delivery,” European Journal of Epidemiology, vol. 26, no. 5, pp. 421–428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Lehtinen, K. A. Ault, E. Lyytikainen et al., “Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia,” Sexually Transmitted Infections, vol. 87, no. 5, pp. 372–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Silva, F. Cerqueira, and R. Medeiros, “Chlamydia trachomatis infection: implications for HPV status and cervical cancer,” Archives of Gynecology and Obstetrics, vol. 289, no. 4, pp. 715–723, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. L. A. Dahlström, K. Andersson, T. Luostarinen et al., “Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer,” Cancer Epidemiology, Biomarkers & Prevention, vol. 20, no. 12, pp. 2541–2550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. K. E. Jensen, L. T. Thomsen, S. Schmiedel et al., “Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study,” Sexually Transmitted Infections, vol. 90, no. 7, pp. 550–555, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Chumduri, R. K. Gurumurthy, P. K. Zadora, Y. Mi, and T. F. Meyer, “Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response,” Cell Host & Microbe, vol. 13, no. 6, pp. 746–758, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. N. Tungsrithong, C. Kasinpila, C. Maneenin et al., “Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 3, pp. 1497–1500, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. P. A. Mardh, L. Westrom, C. von Mecklenburg, and E. Hammar, “Studies on ciliated epithelia of the human genital tract. I. Swelling of the cilia of Fallopian tube epithelium in organ cultures infected with Mycoplasma hominis,” The British Journal of Venereal Diseases, vol. 52, no. 1, pp. 52–57, 1976. View at Google Scholar · View at Scopus
  77. K. Waites and D. Talkington, “New developments in human diseases due to mycoplasmas,” in Mycoplasmas: Pathogenesis, Molecular Biology, and Emerging Strategies for Control, A. Blanchard and G. Browning, Eds., Horizon Scientific Press, Norwich, UK, 2005. View at Google Scholar
  78. A. Baczynska, H. F. Svenstrup, J. Fedder, S. Birkelund, and G. Christiansen, “The use of enzyme-linked immunosorbent assay for detection of Mycoplasma hominis antibodies in infertile women serum samples,” Human Reproduction, vol. 20, no. 5, pp. 1277–1285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Tyagi, “Mycoplasmal antibodies as determined with an enzyme-linked immunosorbent assay, in tubal factor infertility.,” Indian Journal of Medical Sciences, vol. 53, no. 11, pp. 481–485, 1999. View at Google Scholar · View at Scopus
  80. A. Gupta, A. Gupta, S. Gupta, A. Mittal, P. Chandra, and A. K. Gill, “Correlation of mycoplasma with unexplained infertility,” Archives of Gynecology and Obstetrics, vol. 280, no. 6, pp. 981–985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Mareş, D. Socolov, B. Doroftei, A. Botezatu, and C. D. Goia, “The prevalence of some bacterial markers in female patients undergoing an initial infertility evaluation in North-East Romania,” Roumanian Archives of Microbiology and Immunology, vol. 68, no. 3, pp. 171–174, 2009. View at Google Scholar · View at Scopus
  82. I. Günyeli, F. Abike, I. Dünder et al., “Chlamydia, Mycoplasma and Ureaplasma infections in infertile couples and effects of these infections on fertility,” Archives of Gynecology and Obstetrics, vol. 283, no. 2, pp. 379–385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. R. B. Kundsin, “Mycoplasmas in genitourinary tract infection and reproductive failure,” in Progress in Gynecology, S. H. Sturgis and M. L. Taymor, Eds., Grune & Stratton, New York, NY, USA, 1970. View at Google Scholar
  84. H. Gnarpe and J. Friberg, “T mycoplasmas as a possible cause for reproductive failure,” Nature, vol. 242, no. 5393, pp. 120–121, 1973. View at Publisher · View at Google Scholar · View at Scopus
  85. V. Fenkci, M. Yilmazer, and O. C. Aktepe, “Have Ureaplasma urealyticum and Mycoplasma hominis infections any significant effect on female fertility?” Infezioni in Medicina, vol. 10, no. 4, pp. 220–223, 2002. View at Google Scholar · View at Scopus
  86. P. Andreeva and A. Dimitrov, “The microorganisms associated with bacterial vaginosis as a cause of tubal sterility,” Akusherstvo i Ginekologiia, vol. 41, no. 4, pp. 35–39, 2002. View at Google Scholar · View at Scopus
  87. R. M. Viscardi, “Ureaplasma species: role in neonatal morbidities and outcomes,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 99, no. 1, pp. F87–F92, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Kacerovský, M. Pavlovský, and J. Tosner, “Preterm premature rupture of the membranes and genital mycoplasmas,” Acta Medica, vol. 52, no. 3, pp. 117–120, 2009. View at Google Scholar · View at Scopus
  89. B. Larsen and J. Hwang, “Mycoplasma, Ureaplasma, and adverse pregnancy outcomes: a fresh look,” Infectious Diseases in Obstetrics and Gynecology, vol. 2010, Article ID 521921, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Breugelmans, E. Vancutsem, A. Naessens, M. Laubach, and W. Foulon, “Association of abnormal vaginal flora and Ureaplasma species as risk factors for preterm birth: a cohort study,” Acta Obstetricia et Gynecologica Scandinavica, vol. 89, no. 2, pp. 256–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Kacerovský and L. Boudyš, “Preterm premature rupture of membranes and Ureaplasma urealyticum,” Ceska Gynekologie, vol. 73, no. 3, pp. 154–159, 2008. View at Google Scholar · View at Scopus
  92. F. Namba, T. Hasegawa, M. Nakayama et al., “Placental features of chorioamnionitis colonized with Ureaplasma species in preterm delivery,” Pediatric Research, vol. 67, no. 2, pp. 166–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. D. C. Kasper, T. P. Mechtler, G. H. Reischer et al., “The bacterial load of Ureaplasma parvum in amniotic fluid is correlated with an increased intrauterine inflammatory response,” Diagnostic Microbiology and Infectious Disease, vol. 67, no. 2, pp. 117–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Kataoka, T. Yamada, K. Chou et al., “Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy,” Journal of Clinical Microbiology, vol. 44, no. 1, pp. 51–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. D. Taylor-Robinson, P. M. Furr, J. G. Tully, M. F. Barile, and B. R. Møller, “Animal models of Mycoplasma genitalium urogenital infection,” Israel Journal of Medical Sciences, vol. 23, no. 6, pp. 561–564, 1987. View at Google Scholar · View at Scopus
  96. C. Bjartling, S. Osser, and K. Persson, “The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 117, no. 3, pp. 361–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Bjartling, S. Osser, and K. Persson, “Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service,” American Journal of Obstetrics and Gynecology, vol. 206, no. 6, pp. 476.e1–476.e8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. C. L. Haggerty, P. A. Totten, S. G. Astete et al., “Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease,” Sexually Transmitted Infections, vol. 84, no. 5, pp. 338–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. C. L. Haggerty and B. D. Taylor, “Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease,” Infectious Diseases in Obstetrics and Gynecology, vol. 2011, Article ID 959816, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. C. R. Cohen, M. Nosek, A. Meier et al., “Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya,” Sexually Transmitted Diseases, vol. 34, no. 5, pp. 274–279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Jurstrand, J. S. Jensen, A. Magnuson, F. Kamwendo, and H. Fredlund, “A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy,” Sexually Transmitted Infections, vol. 83, no. 4, pp. 319–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. C. L. McGowin and C. Anderson-Smits, “Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women,” PLoS Pathogens, vol. 7, no. 5, Article ID e1001324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Oakeshott, P. Hay, D. Taylor-Robinson et al., “Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 111, no. 12, pp. 1464–1467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. R. Edwards, R. Ferguson, L. Reyes, M. Brown, D. Theriaque, and P. Duff, “Assessing the relationship between preterm delivery and various microorganisms recovered from the lower genital tract,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 19, no. 6, pp. 357–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. J. Hitti, P. Garcia, P. Totten, K. Paul, S. Astete, and K. K. Holmes, “Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women,” Sexually Transmitted Diseases, vol. 37, no. 2, pp. 81–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. A.-C. Labbé, E. Frost, S. Deslandes, A. P. Mendonça, A. C. Alves, and J. Pépin, “Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau,” Sexually Transmitted Infections, vol. 78, no. 4, pp. 289–291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. V. L. Short, J. S. Jensen, D. B. Nelson, P. J. Murray, R. B. Ness, and C. L. Haggerty, “Mycoplasma genitalium among young, urban pregnant women,” Infectious Diseases in Obstetrics and Gynecology, vol. 2010, Article ID 984760, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. H. F. Clausen, J. Fedder, M. Drasbek et al., “Serological investigation of Mycoplasma genitalium in infertile women,” Human Reproduction, vol. 16, no. 9, pp. 1866–1874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  109. H. F. Svenstrup, J. Fedder, S. E. Kristoffersen, B. Trolle, S. Birkelund, and G. Christiansen, “Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility—a prospective study,” Fertility and Sterility, vol. 90, no. 3, pp. 513–520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Grześko, M. Elias, B. Maczyńska, U. Kasprzykowska, M. Tłaczała, and M. Goluda, “Occurrence of Mycoplasma genitalium in fertile and infertile women,” Fertility and Sterility, vol. 91, no. 6, pp. 2376–2380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Baczynska, P. Funch, J. Fedder, H. J. Knudsen, S. Birkelund, and G. Christiansen, “Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominisin vitro organ culture study,” Human Reproduction, vol. 22, no. 4, pp. 968–979, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. G. F. Gonzales, G. Muñoz, R. Sánchez et al., “Update on the impact of Chlamydia trachomatis infection on male fertility,” Andrologia, vol. 36, no. 1, pp. 1–23, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. K. K. Holmes, H. H. Handsfield, S. P. Wang et al., “Etiology of nongonococcal urethritis,” The New England Journal of Medicine, vol. 292, no. 23, pp. 1199–1205, 1975. View at Publisher · View at Google Scholar · View at Scopus
  114. M. D. Kiviat, N. B. Kiviat, and R. E. Berger, “Chlamydia trachomatis epididymitis diagnosed by fluorescent monoclonal antibody,” Urology, vol. 30, no. 4, pp. 395–397, 1987. View at Publisher · View at Google Scholar · View at Scopus
  115. T. H. Trojian, T. S. Lishnak, and D. Heiman, “Epididymitis and orchitis: an overview,” American Family Physician, vol. 79, no. 7, pp. 583–587, 2009. View at Google Scholar · View at Scopus
  116. N. A. F. Walker and B. Challacombe, “Managing epididymo-orchitis in general practice,” The Practitioner, vol. 257, no. 1760, pp. 21–25, 2013. View at Google Scholar · View at Scopus
  117. V. Škerk, S. L. Sternak, S. Roglić, and M. Lisić, “Diagnosis and treatment of chronic prostatitis caused by Chlamydia trachomatis,” Journal of Chemotherapy, vol. 17, no. 5, pp. 570–571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. V. Škerk, I. Krhen, V. Čajić et al., “The role of Chlamydia trachomatis in prostatitis syndrome—our experience in diagnosis and treatment,” Acta Dermatovenerologica Croatica, vol. 15, no. 3, pp. 135–140, 2007. View at Google Scholar · View at Scopus
  119. Y. S. Choi, K. S. Kim, S. W. Choi et al., “Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea,” Prostate International, vol. 1, no. 3, pp. 133–138, 2013. View at Publisher · View at Google Scholar
  120. S. Mazzoli, D. Bani, A. Salvi et al., “In vivo evidence of Chlamydia trachomatis miniature reticulary bodies (MRB) as persistence markers in patients with chronic chlamydial prostatitis,” in Proceedings of the 4th European Society for Chlamydia Research Meeting, p. 40, 2000.
  121. M. A. González-Jiménez and C. A. Villanueva-Díaz, “Epididymal stereocilia in semen of infertile men: evidence of chronic epididymitis?” Andrologia, vol. 38, no. 1, pp. 26–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Eley, A. A. Pacey, M. Galdiero, and F. Galdiero, “Can Chlamydia trachomatis directly damage your sperm?” The Lancet Infectious Diseases, vol. 5, no. 1, pp. 53–57, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. A. Al-Moushaly, “Recent acquisitions in the medical treatment of infertility caused by Chlamydia Trachomatis,” Journal of Medicine and Life, vol. 6, no. 2, pp. 168–170, 2013. View at Google Scholar · View at Scopus
  124. Y.-S. Lee and K.-S. Lee, “Chlamydia and male lower urinary tract diseases,” Korean Journal of Urology, vol. 54, no. 2, pp. 73–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Liu, Q. Wang, X. Ji et al., “Prevalence of Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia trachomatis infections, and semen quality in infertile and fertile men in China,” Urology, vol. 83, no. 4, pp. 795–799, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. S. Hosseinzadeh, I. A. Brewis, A. A. Pacey, H. D. M. Moore, and A. Eley, “Coincubation of human spermatozoa with Chlamydia trachomatis in vitro causes increased tyrosine phosphorylation of sperm proteins,” Infection and Immunity, vol. 68, no. 9, pp. 4872–4876, 2000. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Hosseinzadeh, I. A. Brewis, A. Eley, and A. A. Pacey, “Co-incubation of human spermatozoa with Chlamydia trachomatis serovar E causes premature sperm death,” Human Reproduction, vol. 16, no. 2, pp. 293–299, 2001. View at Publisher · View at Google Scholar · View at Scopus
  128. C. Keck, C. Gerber-Schäfer, A. Clad, C. Wilhelm, and M. Breckwoldt, “Seminal tract infections: impact on male fertility and treatment options,” Human Reproduction Update, vol. 4, no. 6, pp. 891–903, 1998. View at Publisher · View at Google Scholar · View at Scopus
  129. Y. Wang, C.-L. Liang, J.-Q. Wu, C. Xu, S.-X. Qin, and E.-S. Gao, “Do Ureaplasma urealyticum infections in the genital tract affect semen quality?” Asian Journal of Andrology, vol. 8, no. 5, pp. 562–568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. R. B. Kundsin, S. G. Driscoll, and P.-M. L. Ming, “Strain of mycoplasma associated with human reproductive failure,” Science, vol. 157, no. 3796, pp. 1573–1574, 1967. View at Publisher · View at Google Scholar · View at Scopus
  131. J. Friberg and H. Gnarpe, “Mycoplasmas in semen from fertile and infertile men,” Andrologia, vol. 6, no. 1, pp. 45–52, 1974. View at Google Scholar · View at Scopus
  132. K. Purvis and E. Christiansen, “Infection in the male reproductive tract. Impact, diagnosis and treatment in relation to male infertility,” International Journal of Andrology, vol. 16, no. 1, pp. 1–13, 1993. View at Google Scholar · View at Scopus
  133. C. Xu, G. F. Sun, Y. F. Zhu, and Y. F. Wang, “The correlation of Ureaplasma urealyticum infection with infertility,” Andrologia, vol. 29, no. 4, pp. 219–226, 1997. View at Google Scholar · View at Scopus
  134. D. Sanocka-Maciejewska, M. Ciupińska, and M. Kurpisz, “Bacterial infection and semen quality,” Journal of Reproductive Immunology, vol. 67, no. 1-2, pp. 51–56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  135. J. S. Lee, K. T. Kim, H. S. Lee, K. M. Yang, J. T. Seo, and J. H. Choe, “Concordance of Ureaplasma urealyticum and mycoplasma hominis in infertile couples: impact on semen parameters,” Urology, vol. 81, no. 6, pp. 1219–1224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. X.-Y. Xia, L.-M. An, W.-W. Li et al., “Ureaplasma urealyticum infection affects sperm plasma membrane integrity in infertile men,” Zhonghua Nan Ke Xue, vol. 17, no. 12, pp. 1069–1072, 2011. View at Google Scholar · View at Scopus
  137. B. Pajović, N. Radojević, M. Vuković, and A. Stjepčević, “Semen analysis before and after antibiotic treatment of asymptomatic Chlamydia- and Ureaplasma-related pyospermia,” Andrologia, vol. 45, no. 4, pp. 266–271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Salmeri, D. Valenti, S. la Vignera et al., “Prevalence of Ureaplasma urealyticum and Mycoplasma hominis infection in unselected infertile men,” Journal of Chemotherapy, vol. 24, no. 2, pp. 81–86, 2012. View at Publisher · View at Google Scholar · View at Scopus
  139. R. Gdoura, W. Kchaou, C. Chaari et al., “Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men,” BMC Infectious Diseases, vol. 7, article 129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  140. F. J. Díaz-García, A. P. Herrera-Mendoza, S. Giono-Cerezo, and F. M. Guerra-Infante, “Mycoplasma hominis attaches to and locates intracellularly in human spermatozoa,” Human Reproduction, vol. 21, no. 6, pp. 1591–1598, 2006. View at Publisher · View at Google Scholar · View at Scopus
  141. H. F. Svenstrup, J. Fedder, J. Abraham-Peskir, S. Birkelund, and G. Christiansen, “Mycoplasma genitalium attaches to human spermatozoa,” Human Reproduction, vol. 18, no. 10, pp. 2103–2109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  142. J. N. Krieger and D. E. Riley, “Chronic prostatitis: charlottesville to seattle,” Journal of Urology, vol. 172, no. 6, part 2, pp. 2557–2560, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. N. A. Al-Sweih, A. H. Al-Fadli, A. E. Omu, and V. O. Rotimi, “Prevalence of Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections and seminal quality in infertile and fertile men in Kuwait,” Journal of Andrology, vol. 33, no. 6, pp. 1323–1329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. W. E. Stamm, M. Tam, M. Koester, and L. Cles, “Detection of Chlamydia trachomatis inclusions in McCoy cell cultures with fluorescein-conjugated monoclonal antibodies,” Journal of Clinical Microbiology, vol. 17, no. 4, pp. 666–668, 1983. View at Google Scholar · View at Scopus
  145. C. M. Black, “Current methods of laboratory diagnosis of Chlamydia trachomatis infections,” Clinical Microbiology Reviews, vol. 10, no. 1, pp. 160–184, 1997. View at Google Scholar · View at Scopus
  146. A. Visser and A. Hoosen, “Diagnosis of Chlamydia trachomatis infection,” in Chlamydia, M. Mares, Ed., InTech, 2012. View at Google Scholar
  147. R. J. Suchland, W. M. Geisler, and W. E. Stamm, “Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 2, pp. 636–642, 2003. View at Publisher · View at Google Scholar · View at Scopus
  148. S. L. Sternak and V. Škerk, “Determining antimicrobial resistance to Chlamydia trachomatis and applying present findings in daily practice,” Medicinski Glasnik, vol. 7, no. 1, pp. 26–31, 2010. View at Google Scholar · View at Scopus
  149. H. Zeighami, S. N. Peerayeh, and M. Safarlu, “Detection of Ureaplasma urealyticum in semen of infertile men by PCR,” Pakistan Journal of Biological Sciences, vol. 10, no. 21, pp. 3960–3963, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. X. Cao, Z. Jiang, Y. Wang, R. Gong, and C. Zhang, “Two multiplex real-time TaqMan polymerase chain reaction systems for simultaneous detecting and serotyping of Ureaplasma parvum,” Diagnostic Microbiology and Infectious Disease, vol. 59, no. 1, pp. 109–111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. M. J. Redelinghuys, M. M. Ehlers, A. W. Dreyer, H. A. Lombaard, and M. M. Kock, “Comparison of the new Mycofast Revolution assay with a molecular assay for the detection of genital mycoplasmas from clinical specimens,” BMC Infectious Diseases, vol. 13, no. 1, article 453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  152. J. S. Jensen, “Mycoplasma genitalium infections. Diagnosis clinical aspects, and pathogenesis,” Danish Medical Journal, vol. 53, no. 1, pp. 1–27, 2006. View at Google Scholar · View at Scopus
  153. H. Thejls, J. Gnarpe, H. Gnarpe et al., “Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology,” Genitourinary Medicine, vol. 70, no. 5, pp. 300–303, 1994. View at Google Scholar · View at Scopus
  154. J. A. Kellogg, J. W. Seiple, and M. E. Hick, “Cross-reaction of clinical isolates of bacteria and yeasts with the Chlamydiazyme test for Chlamydial antigen, before and after use of a blocking reagent,” American Journal of Clinical Pathology, vol. 97, no. 3, pp. 309–312, 1992. View at Google Scholar · View at Scopus
  155. S. V. Jalgaonkar, A. A. Pathak, Y. S. Thakar, and M. M. Kher, “Enzyme immunoassay for rapid detection of Chlamydia trachomatis in urogenital infections,” Indian Journal of Sexually Transmitted Diseases, vol. 11, no. 1, pp. 23–26, 1990. View at Google Scholar · View at Scopus
  156. J. B. Mahony, K. E. Luinstra, J. W. Sellors, and M. A. Chernesky, “Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids,” Journal of Clinical Microbiology, vol. 31, no. 7, pp. 1753–1758, 1993. View at Google Scholar · View at Scopus
  157. J. K. Møller, L. N. Pedersen, and K. Persson, “Comparison of the Abbott RealTime CT new formulation assay with two other commercial assays for detection of wild-type and new variant strains of Chlamydia trachomatis,” Journal of Clinical Microbiology, vol. 48, no. 2, pp. 440–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. M. Hartmann, “Genital mycoplasmas,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 7, no. 4, pp. 371–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. K. B. Waites, L. Xiao, V. Paralanov, R. M. Viscardi, and J. I. Glass, “Molecular methods for the detection of Mycoplasma and Ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital symposium on molecular pathology,” Journal of Molecular Diagnostics, vol. 14, no. 5, pp. 437–450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  160. M. A. Meseguer-Peinado, B. Acosta-Boga, L. Matas-Andreu, and G. Codina-Grau, “Microbiological diagnosis of Mycoplasma infections,” Enfermedades Infecciosas y Microbiología Clínica, vol. 30, no. 8, pp. 500–504, 2012. View at Publisher · View at Google Scholar · View at Scopus
  161. Y. Kim, J. Kim, and K.-A. Lee, “Prevalence of sexually transmitted infections among healthy Korean women: implications of multiplex PCR pathogen detection on antibiotic therapy,” Journal of Infection and Chemotherapy, vol. 20, no. 1, pp. 74–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  162. H.-S. Choe, D. S. Lee, S.-J. Lee et al., “Performance of Anyplex II multiplex real-time PCR for the diagnosis of seven sexually transmitted infections: comparison with currently available methods,” International Journal of Infectious Diseases, vol. 17, no. 12, pp. e1134–e1140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  163. M. L. McKechnie, F. Kong, and G. L. Gilbert, “Simultaneous direct identification of genital microorganisms in voided urine using multiplex PCR-based reverse line blot assays,” Methods in Molecular Biology, vol. 943, pp. 229–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  164. M. Schmitt, C. Depuydt, M. Stalpaert, and M. Pawlita, “Bead-based multiplex sexually transmitted infection profiling,” Journal of Infection, vol. 69, no. 2, pp. 123–133, 2014. View at Publisher · View at Google Scholar · View at Scopus
  165. A. Arsovic, A. Nikolov, P. Sazdanovic, S. Popovic, and D. Baskic, “Prevalence and diagnostic significance of specific IgA and anti-heat shock protein 60 Chlamydia trachomatis antibodies in subfertile women,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 33, no. 5, pp. 761–766, 2014. View at Publisher · View at Google Scholar · View at Scopus
  166. Z. Raoofi, M. Barchinegad, and L. Haghighi, “The value of negative Chlamydia trachomatis antibody in prediction of normal tubes in infertile women,” Clinical and Experimental Obstetrics and Gynecology, vol. 40, no. 1, pp. 95–97, 2013. View at Google Scholar · View at Scopus
  167. J. N. Arno, Y. Yuan, R. E. Cleary, and R. P. Morrison, “Serologic responses of infertile women to the 60-kd chlamydial heat shock protein (hsp60),” Fertility and Sterility, vol. 64, no. 4, pp. 730–735, 1995. View at Google Scholar · View at Scopus
  168. P. Claman, L. Honey, R. W. Peeling, P. Jessamine, and B. Toye, “The presence of serum antibody to the chlamydial heat shock protein (CHSP60) as a diagnostic test for tubal factor infertility,” Fertility and Sterility, vol. 67, no. 3, pp. 501–504, 1997. View at Publisher · View at Google Scholar · View at Scopus
  169. C. J. Bax, P. J. Dörr, J. B. Trimbos et al., “Chlamydia trachomatis heat shock protein 60 (cHSP60) antibodies in women without and with tubal pathology using a new commercially available assay,” Sexually Transmitted Infections, vol. 80, no. 5, pp. 415–416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  170. C. M. Gazzard, R. N. Wood, J. Debattista, J. A. Allan, J. M. Allan, and P. Timms, “Use of a commercial assay for detecting the 60 kDa chlamydial heat shock protein in a range of patient groups,” Sexually Transmitted Diseases, vol. 33, no. 2, pp. 77–79, 2006. View at Publisher · View at Google Scholar · View at Scopus
  171. T. Collet, T. Macnaughton, T. Walsh, J. Debattista, and P. Timms, “Identification of novel markers for uncomplicated lower genital tract infections and upper genital tract pathology due to Chlamydia trachomatis,” International Journal of Infectious Diseases, vol. 15, no. 4, pp. e257–e266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  172. D. Taylor-Robinson, P. M. Furr, and J. G. Tully, “Serological cross-reactions between Mycoplasma genitalium and M. pneumoniae,” The Lancet, vol. 1, no. 8323, p. 527, 1983. View at Google Scholar · View at Scopus
  173. R. Y.-H. Wang, T. Grandinetti, J. W.-K. Shih et al., “Mycoplasma genitalium infection and host antibody immune response in patients infected by HIV, patients attending STD clinics and in healthy blood donors,” FEMS Immunology and Medical Microbiology, vol. 19, no. 3, pp. 237–245, 1997. View at Publisher · View at Google Scholar · View at Scopus
  174. M. Donati, A. di Francesco, A. D'Antuono et al., “In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 12, pp. 5379–5380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. S. Ljubin-Sternak, T. Mestrovic, T. Vilibic-Cavlek et al., “In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate,” Folia Microbiologica, vol. 58, no. 5, pp. 361–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  176. R. B. Jones, B. van der Pol, D. H. Martin, and M. K. Shepard, “Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics,” The Journal of Infectious Diseases, vol. 162, no. 6, pp. 1309–1315, 1990. View at Publisher · View at Google Scholar · View at Scopus
  177. J. Somani, V. B. Bhullar, K. A. Workowski, C. E. Farshy, and C. M. Black, “Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure,” The Journal of Infectious Diseases, vol. 181, no. 4, pp. 1421–1427, 2000. View at Publisher · View at Google Scholar · View at Scopus
  178. A. R. Bhengraj, H. Vardhan, P. Srivastava, S. Salhan, and A. Mittal, “Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India,” Chemotherapy, vol. 56, no. 5, pp. 371–377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. K. M. Sandoz and D. D. Rockey, “Antibiotic resistance in Chlamydiae,” Future Microbiology, vol. 5, no. 9, pp. 1427–1442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  180. N. Kechagia, S. Bersimis, and S. Chatzipanagiotou, “Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 1, pp. 122–125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  181. C. M. Bébéar and C. Bébéar, “Antimycoplasmal agents,” in Molecular Biology and Pathogenicity of Mycoplasmas, S. Razin and R. Herrmann, Eds., Kluwer Academic/Plenum, London, UK, 2002. View at Publisher · View at Google Scholar
  182. M. Dongya, X. Wencheng, M. Xiaobo, and W. Lu, “Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum,” Microbial Drug Resistance, vol. 14, no. 3, pp. 183–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  183. L. Xiao, D. M. Crabb, L. B. Duffy et al., “Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp,” International Journal of Antimicrobial Agents, vol. 37, no. 4, pp. 377–379, 2011. View at Publisher · View at Google Scholar · View at Scopus
  184. S. Dégrange, H. Renaudin, A. Charron, C. Bébéar, and C. M. Bébéar, “Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 2, pp. 742–744, 2008. View at Publisher · View at Google Scholar · View at Scopus
  185. B. B. A. Mardassi, N. Aissani, I. Moalla, D. Dhahri, A. Dridi, and B. Mlik, “Evidence for the predominance of a single tet(M) gene sequence type in tetracycline-resistant Ureaplasma parvum and Mycoplasma hominis isolates from Tunisian patients,” Journal of Medical Microbiology, vol. 61, no. 9, pp. 1254–1261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  186. M. J. Redelinghuys, M. M. Ehlers, A. W. Dreyer, H. A. Lombaard, and M. M. Kock, “Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women,” BMC Infectious Diseases, vol. 14, no. 1, article 171, 2014. View at Publisher · View at Google Scholar · View at Scopus
  187. L. A. Mena, T. F. Mroczkowski, M. Nsuami, and D. H. Martin, “A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men,” Clinical Infectious Diseases, vol. 48, no. 12, pp. 1649–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  188. D. Taylor-Robinson, “Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts,” Expert Review of Anti-Infective Therapy, vol. 12, no. 6, pp. 715–722, 2014. View at Publisher · View at Google Scholar · View at Scopus
  189. C. Anagrius, B. Loré, and J. S. Jensen, “Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic,” PLoS ONE, vol. 8, no. 4, Article ID e61481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  190. M. J. Pond, A. V. Nori, A. A. Witney, R. C. Lopeman, P. D. Butcher, and S. T. Sadiq, “High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options,” Clinical Infectious Diseases, vol. 58, no. 5, pp. 631–637, 2014. View at Publisher · View at Google Scholar · View at Scopus
  191. R. Hamasuna, “Identification of treatment strategies for Mycoplasma genitalium-related urethritis in male patients by culturing and antimicrobial susceptibility testing,” Journal of Infection and Chemotherapy, vol. 19, no. 1, pp. 1–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  192. D. L. Couldwell, K. A. Tagg, N. J. Jeoffreys, and G. L. Gilbert, “Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance,” International Journal of STD & AIDS, vol. 24, no. 10, pp. 822–828, 2013. View at Publisher · View at Google Scholar · View at Scopus
  193. M. Kikuchi, S. Ito, M. Yasuda et al., “Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 9, pp. 2376–2382, 2014. View at Publisher · View at Google Scholar
  194. T. Deguchi, M. Kikuchi, M. Yasuda, and S. Ito, “Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV,” Journal of Infection and Chemotherapy, 2014. View at Publisher · View at Google Scholar
  195. S. A. Herzog, J. C. M. Heijne, P. Scott, C. L. Althaus, and N. Low, “Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study,” Epidemiology, vol. 24, no. 6, pp. 854–862, 2013. View at Publisher · View at Google Scholar · View at Scopus
  196. C. Bjartling and K. Persson, “Chlamydia and genital mycoplasma: epidemiology and risks,” Lakartidningen, vol. 107, no. 6, pp. 341–345, 2010. View at Google Scholar · View at Scopus
  197. S. L. Gottlieb, S. M. Berman, and N. Low, “Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?” The Journal of Infectious Diseases, vol. 201, supplement 2, pp. S156–S167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  198. I. Simms, F. Warburton, and L. Weström, “Diagnosis of pelvic inflammatory disease: time for a rethink,” Sexually Transmitted Infections, vol. 79, no. 6, pp. 491–494, 2003. View at Publisher · View at Google Scholar · View at Scopus
  199. L. J. Jackson, P. Auguste, N. Low, and T. E. Roberts, “Valuing the health states associated with Chlamydia trachomatis infections and their sequelae: a systematic review of economic evaluations and primary studies,” Value in Health, vol. 17, no. 1, pp. 116–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  200. W. M. Huston, M. Harvie, A. Mittal, P. Timms, and K. W. Beagley, “Vaccination to protect against infection of the female reproductive tract,” Expert Review of Clinical Immunology, vol. 8, no. 1, pp. 81–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  201. D. C. W. Mabey, V. Hu, R. L. Bailey, M. J. Burton, and M. J. Holland, “Towards a safe and effective chlamydial vaccine: lessons from the eye,” Vaccine, vol. 32, no. 14, pp. 1572–1578, 2014. View at Publisher · View at Google Scholar · View at Scopus
  202. S. Vasilevsky, G. Greub, D. Nardelli-Haefliger, and D. Baud, “Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research,” Clinical Microbiology Reviews, vol. 27, no. 2, pp. 346–370, 2014. View at Publisher · View at Google Scholar · View at Scopus